Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis

BACKGROUND: Adherence to disease-modifying drugs (DMDs) is one of the key factors for achieving optimal clinical outcomes. Rebismart(®) is an injection device for subcutaneous administration of interferon beta-1a (INF β-1a) that is also able to monitor adherence objectively. The aim of this study wa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Patient Prefer Adherence
Asıl Yazarlar: Edo Solsona, María Dolores, Monte Boquet, Emilio, Casanova Estruch, Bonaventura, Poveda Andrés, José Luis
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5338953/
https://ncbi.nlm.nih.gov/pubmed/28280313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S127508
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller